The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

Creative Commons License

Kocaturk E., SALMAN A., Cherrez-Ojeda I., Criado P. R., Peter J., Comert-Ozer E., ...More

ALLERGY, vol.76, no.3, pp.816-830, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 76 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.1111/all.14687
  • Journal Name: ALLERGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.816-830
  • Keywords: chronic urticaria, COVID-19, cyclosporine, omalizumab, pandemic, SARS-CoV-2, treatment, UCARE, ASSOCIATION, INFECTIONS, OMALIZUMAB, STRESS, SERUM
  • Istanbul University Affiliated: Yes


Introduction The COVID-19 pandemic dramatically disrupts health care around the globe. The impact of the pandemic on chronic urticaria (CU) and its management are largely unknown.